Ishita Drugs and Industries Limited (BOM:524400)

BOM:524400 Revenue

In the fiscal year ending March 31, 2026, Ishita Drugs and Industries had annual revenue of 146.60M INR, down -2.25%. Ishita Drugs and Industries had revenue of 32.74M in the quarter ending March 31, 2026, a decrease of -28.26%.

• Revenue: 146.60M
• Revenue Growth: -2.25%
• P/S Ratio: 1.44
• Revenue / Employee: 10.47M
• Employees: 14
• Market Cap: 211.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	146.60M	-3.37M	-2.25%
Mar 31, 2025	149.97M	-1.90M	-1.25%
Mar 31, 2024	151.88M	31.15M	25.81%
Mar 31, 2023	120.72M	-20.18M	-14.32%
Mar 31, 2022	140.90M	1.41M	1.01%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error